160 related articles for article (PubMed ID: 20096921)
1. The association between metabolic abnormality and endometrial cancer: a large case-control study in China.
Zhang Y; Liu Z; Yu X; Zhang X; Lü S; Chen X; Lü B
Gynecol Oncol; 2010 Apr; 117(1):41-6. PubMed ID: 20096921
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors.
Saltzman BS; Doherty JA; Hill DA; Beresford SA; Voigt LF; Chen C; Weiss NS
Am J Epidemiol; 2008 Mar; 167(5):607-14. PubMed ID: 18071194
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer.
Friedenreich CM; Biel RK; Lau DC; Csizmadi I; Courneya KS; Magliocco AM; Yasui Y; Cook LS
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2384-95. PubMed ID: 21921255
[TBL] [Abstract][Full Text] [Related]
4. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
[TBL] [Abstract][Full Text] [Related]
5. Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women.
Xu WH; Matthews CE; Xiang YB; Zheng W; Ruan ZX; Cheng JR; Gao YT; Shu XO
Am J Epidemiol; 2005 May; 161(10):939-47. PubMed ID: 15870158
[TBL] [Abstract][Full Text] [Related]
6. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.
Furberg AS; Veierød MB; Wilsgaard T; Bernstein L; Thune I
J Natl Cancer Inst; 2004 Aug; 96(15):1152-60. PubMed ID: 15292387
[TBL] [Abstract][Full Text] [Related]
7. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and risk of endometrial cancer: a population-based prospective cohort study.
Friberg E; Mantzoros CS; Wolk A
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):276-80. PubMed ID: 17301260
[TBL] [Abstract][Full Text] [Related]
9. Weight history and risk of endometrial cancer among Chinese women.
Xu WH; Xiang YB; Zheng W; Zhang X; Ruan ZX; Cheng JR; Gao YT; Shu XO
Int J Epidemiol; 2006 Feb; 35(1):159-66. PubMed ID: 16258056
[TBL] [Abstract][Full Text] [Related]
10. Association of endometrial cancer risk with a functional polymorphism (Asp(327)Asn) in the sex hormone-binding globulin gene.
Kataoka N; Cai Q; Xu WH; Xiang YB; Cai H; Zheng W; Shu XO
Cancer; 2007 Apr; 109(7):1296-302. PubMed ID: 17315164
[TBL] [Abstract][Full Text] [Related]
11. Association between adiponectin, insulin resistance, and endometrial cancer.
Soliman PT; Wu D; Tortolero-Luna G; Schmeler KM; Slomovitz BM; Bray MS; Gershenson DM; Lu KH
Cancer; 2006 Jun; 106(11):2376-81. PubMed ID: 16639730
[TBL] [Abstract][Full Text] [Related]
12. Diabetes and endometrial cancer in the Iowa women's health study.
Anderson KE; Anderson E; Mink PJ; Hong CP; Kushi LH; Sellers TA; Lazovich D; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):611-6. PubMed ID: 11401910
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and endometrial carcinoma.
Bjørge T; Stocks T; Lukanova A; Tretli S; Selmer R; Manjer J; Rapp K; Ulmer H; Almquist M; Concin H; Hallmans G; Jonsson H; Stattin P; Engeland A
Am J Epidemiol; 2010 Apr; 171(8):892-902. PubMed ID: 20219764
[TBL] [Abstract][Full Text] [Related]
16. Genetics, obesity, and environmental risk factors associated with type 2 diabetes.
Bener A; Zirie M; Al-Rikabi A
Croat Med J; 2005 Apr; 46(2):302-7. PubMed ID: 15849854
[TBL] [Abstract][Full Text] [Related]
17. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
Misra KB; Endemann SW; Ayer M
Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.
Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA
J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694
[TBL] [Abstract][Full Text] [Related]
19. [Obesity at different ages and endometrial cancer risk factors in urban Shanghai, China].
Xu W; Dai Q; Ruan Z; Cheng J; Jin F; Shu X
Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Oct; 23(5):347-51. PubMed ID: 12482364
[TBL] [Abstract][Full Text] [Related]
20. Use of body mass index to identify obesity-related metabolic disorders in the Chinese population.
Weng X; Liu Y; Ma J; Wang W; Yang G; Caballero B
Eur J Clin Nutr; 2006 Aug; 60(8):931-7. PubMed ID: 16465198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
